ADAM10 and Cognitive impairment: In this case, it has been elucidated that treatment of APP/PS1 mice with a cell-permeable peptide (PEP3), which interferes with ADAM10 endocytosis, contributes to upregulate the postsynaptic localization and activity of ADAM10 and eventually, promote synaptic plasticity and improve cognitive deficit [69].